Avalo Therapeutics Inc (NAS:AVTX)
$ 11.4501 -0.1799 (-1.55%) Market Cap: 11.84 Mil Enterprise Value: -86.15 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Avalo Therapeutics Inc at Jefferies Healthcare Conference Transcript

Jun 09, 2023 / 03:00PM GMT
Release Date Price: $964.8 (-3.13%)
Chris Howerton
(Trades, Portfolio) LLC - Analyst

Great. Thank you so much for joining us again. My name is Chris Howerton, part of the Jefferies's biotechnology research team. Starting a little bit late, but we're here with Avalo Therapeutics. And on behalf of the company, we have the Chairman and CEO, Dr. Garry Neil. So thanks for joining us.

Garry Neil
Avalo Therapeutics, Inc. - Chairman & CEO

Thanks, Chris. Pleasure to be here.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot